Researchers discover receptor that protects against allergies, asthma

February 26, 2018, Johns Hopkins University Bloomberg School of Public Health
Credit: CC0 Public Domain

A special receptor on cells that line the sinuses, throat and lungs evolved to protect mammals from developing a range of allergies and asthma, according to a study from researchers at Johns Hopkins Bloomberg School of Public Health.

The scientists found that the receptor, dectin-1, recognizes a protein found in house dust mites, cockroaches, shellfish and other invertebrates, and responds by suppressing immune reactions to these common triggers of allergy and . The scientists also found evidence that this protective mechanism is dramatically impaired in people who have asthma or chronic sinusitis due to dust-mite sensitivity.

"Everyone is exposed to these substances, yet most don't have allergic responses to them, and this mechanism we've discovered appears to explain why," says study senior author Marsha Wills-Karp, PhD, Anna M. Baetjer Professor in Environmental Health at the Bloomberg School and chair of the Department of Environmental Health and Engineering.

The finding, which was published online February 23 in Science Immunology, suggests there may be new ways to treat or prevent allergies and asthma, which afflict tens of millions of people in the U.S. alone. The discovery also hints that while dectin-1 protects against dust-mite and other invertebrate-related allergic responses, there may be additional, undiscovered receptors that suppress allergic responses to pollens and other airborne and dietary allergens.

Dectin-1 previously has been studied as a receptor that recognizes structures on fungi and other microbes and triggers immune responses to them. There have even been suggestions that dectin-1 helps trigger allergic responses to dust mites. To investigate, Wills-Karp and colleagues, including postdoctoral researcher Naina Gour, PhD, and assistant scientist Stephane Lajoie, PhD, who were first authors of the study, studied mice that were genetically engineered to lack dectin-1.

The researchers found to their surprise that the airways of these dectin-1-deficient mice were more prone to inflammation after exposure to dust mites compared to otherwise identical mice whose airway cells expressed dectin-1 normally. Blocking dectin-1 with antibodies had the same allergy-promoting effect. Thus, dectin-1 protects against dust-mite allergies rather than promoting them.

The scientists determined that dectin-1, in addition to its fungus- and other pathogen-detecting duties, directly recognizes a protein called tropomyosin that is found in house dust mites and other invertebrates. Tropomyosin has previously been implicated as a possible trigger for asthma and shrimp allergies.

The experiments indicated that when dectin-1 recognizes tropomyosin in house dust mites, shrimp or other common allergy-triggering species it suppresses airway cells' production of an immune molecule, IL-33, which otherwise would promote an by immune cells.

Underscoring the relevance to humans, the researchers studied nasal and bronchial cells from people who suffer from asthma or chronic rhinosinusitis (nasal congestion/sniffles) due to dust-mite sensitivity, and found that on average these cells had a markedly lower expression of the dectin-1 gene. The team also examined data from a prior genetic study of children with asthma and found that a variant of the dectin-1 gene—which reduces production of the receptor—is strongly linked to increased asthma risk.

"Our findings suggest that people who have sufficient dectin-1 in the cells that line their airways won't experience an allergic response when exposed to airborne dust mites or related allergens—but people with a defect in dectin-1 expression will lack this protection," Wills-Karp says.

The findings point to the possibility of boosting dectin-1 levels, or otherwise restoring its protective effect, as a new therapeutic strategy against asthma and allergies that are related to , shrimp or other invertebrate triggers.

The study showed that dectin-1 does not recognize pollens, another major source of allergies. However, Wills-Karp expects that other receptors on recognize these ubiquitous plant-derived allergens and she hopes to find them in future research.

Explore further: Research reveals possible new treatment pathway for severe allergic asthma

More information: Naina Gour et al. Dysregulated invertebrate tropomyosin–dectin-1 interaction confers susceptibility to allergic diseases, Science Immunology (2018). DOI: 10.1126/sciimmunol.aam9841

Related Stories

Research reveals possible new treatment pathway for severe allergic asthma

October 13, 2017
Research demonstrates that blocking the action of two pro-inflammatory molecules significantly reduces symptoms of allergic asthma in mice, which could lead to development of a new treatment for people with a severe form ...

Treating eczema could also alleviate asthma

January 19, 2018
Scientists from VIB-UGent have discovered insights for a possible new therapy for eczema that also reduces the severity of asthma. The findings are an important next step in understanding the relationship between the two ...

Allergies induced by dust mites can harm DNA in lung cells

May 3, 2016
House dust mites, which are a major source of allergens in house dust, can cause asthma in adults and children. Researchers from MIT and the National University of Singapore have now found that these mites have a greater ...

Scientists find receptor that puts the brakes on allergic response

April 1, 2016
Up to 40% of the world's population has allergic rhinitis, commonly known as an allergy. A Yale-led study has identified an important receptor protein that regulates the intensity of the immune response to allergens. Their ...

Molecular origins of allergy to house dust mites discovered

October 25, 2016
Scientists at the Charité - Universitätsmedizin Berlin found which molecules of the house dust mites are initially targeted by the immune system of children developing, even years later, allergic rhinitis and asthma. The ...

Recommended for you

Scientists create most accurate tool yet developed to predict asthma in young children

December 13, 2018
Scientists at Cincinnati Children's Hospital Medical Center have created and tested a decision tool that appears to be the most accurate, non-invasive method yet developed to predict asthma in young children.

New genetic study could lead to better treatment of severe asthma

December 12, 2018
The largest-ever genetic study of people with moderate-to-severe asthma has revealed new insights into the underlying causes of the disease which could help improve its diagnosis and treatment.

Researchers discover unique immune cell likely drives chronic inflammation

December 11, 2018
For the first time, researchers have identified that an immune cell subset called gamma delta T cells that may be causing and/or perpetuating the systemic inflammation found in normal aging in the general geriatric population ...

Macrophage cells key to helping heart repair—and potentially regenerate, new study finds

December 11, 2018
Scientists at the Peter Munk Cardiac Centre have identified the type of cell key to helping the heart repair and potentially regenerate following a heart attack.

Study identifies a key cellular mechanism that triggers pneumonia in humans

December 11, 2018
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted ...

Immune cells sacrifice themselves to protect us from invading bacteria

December 11, 2018
Immune systems are working overtime as winter approaches. Stomach flu can turn the strongest individual into a bedridden convalescent. Viruses are spreading in kindergartens. This year's flu is approaching in full swing. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.